Q3 EPS Estimates for Henry Schein Boosted by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Investment analysts at Zacks Research lifted their Q3 2025 EPS estimates for shares of Henry Schein in a report issued on Monday, May 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.27 per share for the quarter, up from their previous estimate of $1.26. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein's Q3 2026 earnings at $1.35 EPS.

A number of other equities research analysts have also recently issued reports on HSIC. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. UBS Group cut their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Wells Fargo & Company decreased their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Piper Sandler cut their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Finally, Barrington Research dropped their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Stock Performance

HSIC traded down $0.44 during trading hours on Thursday, reaching $69.55. The company's stock had a trading volume of 1,135,312 shares, compared to its average volume of 1,670,161. The company's 50-day moving average is $67.65 and its 200-day moving average is $71.69. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49. The firm has a market cap of $8.47 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.10 earnings per share.

Insider Buying and Selling

In related news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is owned by company insiders.

Institutional Trading of Henry Schein

Large investors have recently bought and sold shares of the company. Smartleaf Asset Management LLC raised its holdings in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares in the last quarter. Guggenheim Capital LLC grew its holdings in shares of Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after buying an additional 159 shares during the last quarter. CIBC Asset Management Inc grew its holdings in shares of Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after buying an additional 169 shares during the last quarter. Metis Global Partners LLC increased its position in shares of Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after acquiring an additional 187 shares in the last quarter. Finally, UMB Bank n.a. raised its holdings in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.